Journal of the National Cancer Institute Advance Access originally published online on May 27, 2008
JNCI Journal of the National Cancer Institute 2008 100(11):826-827; doi:10.1093/jnci/djn041
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Re: Prospective Study of Vitamin D and Cancer Mortality in the United States
Affiliations of authors: Department of Family and Preventive Medicine and Moores UCSD Cancer Center, University of California, San Diego, CA (CFG, EDG, FCG); GrassrootsHealth, Encinitas, CA (CAB)
Correspondence to: Cedric F. Garland, DrPH, FACE, Department of Family and Preventive Medicine and Moores UCSD Cancer Center, University of California, San Diego, 9500 Gilman Dr, 0631, La Jolla, CA 92093 (e-mail: cgarland@ucsd.edu).
| The first 10% of the full text of this article appears below. |
Scientists vary in their approaches to interpreting data. Still, we are concerned that Freedman et al. (1) rejected evidence of a substantial protective association of serum 25-hydroxyvitamin D (25[OH]D) on mortality rates from breast cancer due to incorrect use of a statistical procedure.
The mortality rate from breast cancer was statistically significantly lower in women
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 827-828.